📍 Chicago, IL
Tempus AI logo
Public Company

Tempus AI

Clinical AI and precision medicine company with the largest multimodal clinical dataset — 40+ million records powering genomic testing and oncology AI. $1.27 billion revenue.

Listen to this lesson

Free preview · first 0:30
0:00 / 0:30

Audio & video lessons are paid features

Plus unlocks audio streaming. Pro adds downloadable audio, video, certificates, and more.

Plus adds:
  • Audio streaming
  • Downloadable PDFs
  • All AI Playbooks
  • Personalized content
Pro also adds:
  • Certificates of completion
  • Audio MP3 downloads
  • Video lessonssoon
  • & More…soon

Watch this lesson

Video coming soon

Learn About Tempus AI's AI Products

Create a free account to access in-depth lessons on each tool and model.

Start Learning Free

📋About Tempus AI

Updated June 15, 2026

Tempus AI (NASDAQ: TEM) is a clinical AI and precision medicine company that uses the largest multimodal clinical dataset in the industry — 40+ million records and 1.1 billion healthcare records — to help oncologists select the most effective targeted therapies. Founded by Eric Lefkofsky, Tempus combines genomic testing, AI software, and data licensing with $1.27 billion in 2025 revenue.

🛠️Products & Tools (1)

Tempus AIEnterpriseHealthcare AI

Clinical AI platform analyzing genomic and molecular data to help oncologists select the most effective targeted therapies for individual cancer patients.